Oral Anticoagulation Use and Left Atrial Appendage Occlusion in LAAOS III

Area of Science:

• Cardiology
• Vascular Surgery
• Thrombosis Research

Background:

• Left atrial appendage (LAA) occlusion is proven to reduce stroke risk in atrial fibrillation patients during cardiac surgery.
• Variations in oral anticoagulant (OAC) therapy use may influence the effectiveness of LAA occlusion.

Purpose of the Study:

• To examine the impact of LAA occlusion on stroke risk reduction in relation to OAC therapy use.
• To determine if LAA occlusion's benefits are independent of OAC use.

Main Methods:

• Utilized data from the LAAOS III trial, collecting OAC use information at follow-up visits.
• Employed adjusted proportional hazards modeling with time-dependent covariates to analyze stroke risk.
• Evaluated stroke risk at multiple time points post-randomization.

Main Results:

• LAA occlusion demonstrated consistent stroke risk reduction across patient groups with varying OAC use (HRs ranging from 0.63 to 0.76).
• Analysis using OAC use as a time-dependent covariate indicated similar stroke reduction with LAA occlusion, irrespective of OAC status.

Conclusions:

• The thromboembolic risk reduction benefit of LAA occlusion is consistent, regardless of concurrent OAC therapy.
• LAA occlusion offers a valuable stroke prevention strategy for atrial fibrillation patients independent of their OAC use.